Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation - PubMed (original) (raw)
Resveratrol promotes autophagic cell death in chronic myelogenous leukemia cells via JNK-mediated p62/SQSTM1 expression and AMPK activation
Alexandre Puissant et al. Cancer Res. 2010.
Abstract
Autophagy that is induced by starvation or cellular stress can enable cancer cell survival by sustaining energy homeostasis and eliminating damaged organelles and proteins. In response to stress, cancer cells have been reported to accumulate the protein p62/SQSTM1 (p62), but its role in the regulation of autophagy is controversial. Here, we report that the plant phytoalexin resveratrol (RSV) triggers autophagy in imatinib-sensitive and imatinib-resistant chronic myelogenous leukemia (CML) cells via JNK-dependent accumulation of p62. JNK inhibition or p62 knockdown prevented RSV-mediated autophagy and antileukemic effects. RSV also stimulated AMPK, thereby inhibiting the mTOR pathway. AMPK knockdown or mTOR overexpression impaired RSV-induced autophagy but not JNK activation. Lastly, p62 expression and autophagy in CD34+ progenitors from patients with CML was induced by RSV, and disrupting autophagy protected CD34+ CML cells from RSV-mediated cell death. We concluded that RSV triggered autophagic cell death in CML cells via both JNK-mediated p62 overexpression and AMPK activation. Our findings show that the JNK and AMPK pathways can cooperate to eliminate CML cells via autophagy.
Similar articles
- AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia.
Puissant A, Auberger P. Puissant A, et al. Autophagy. 2010 Jul;6(5):655-7. doi: 10.4161/auto.6.5.12126. Epub 2010 Jul 1. Autophagy. 2010. PMID: 20458181 - Hsp90 inhibitor, BIIB021, induces apoptosis and autophagy by regulating mTOR-Ulk1 pathway in imatinib-sensitive and -resistant chronic myeloid leukemia cells.
He W, Ye X, Huang X, Lel W, You L, Wang L, Chen X, Qian W. He W, et al. Int J Oncol. 2016 Apr;48(4):1710-20. doi: 10.3892/ijo.2016.3382. Epub 2016 Feb 8. Int J Oncol. 2016. PMID: 26892093 - Resveratrol-induced autophagy and apoptosis in cisplatin-resistant human oral cancer CAR cells: A key role of AMPK and Akt/mTOR signaling.
Chang CH, Lee CY, Lu CC, Tsai FJ, Hsu YM, Tsao JW, Juan YN, Chiu HY, Yang JS, Wang CC. Chang CH, et al. Int J Oncol. 2017 Mar;50(3):873-882. doi: 10.3892/ijo.2017.3866. Epub 2017 Jan 30. Int J Oncol. 2017. PMID: 28197628 - p62/SQSTM1/A170: physiology and pathology.
Komatsu M, Kageyama S, Ichimura Y. Komatsu M, et al. Pharmacol Res. 2012 Dec;66(6):457-62. doi: 10.1016/j.phrs.2012.07.004. Epub 2012 Jul 25. Pharmacol Res. 2012. PMID: 22841931 Review. - Role of p62/SQSTM1 in liver physiology and pathogenesis.
Manley S, Williams JA, Ding WX. Manley S, et al. Exp Biol Med (Maywood). 2013 May;238(5):525-38. doi: 10.1177/1535370213489446. Exp Biol Med (Maywood). 2013. PMID: 23856904 Free PMC article. Review.
Cited by
- How do cancer cells replenish their fuel supply?
Alameddine AK, Conlin FT, Binnall BJ, Alameddine YA, Alameddine KO. Alameddine AK, et al. Cancer Rep (Hoboken). 2018 Jun;1(1):e1003. doi: 10.1002/cnr2.1003. Epub 2018 Apr 30. Cancer Rep (Hoboken). 2018. PMID: 32729259 Free PMC article. Review. - Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy.
Fulda S, Kögel D. Fulda S, et al. Oncogene. 2015 Oct 1;34(40):5105-13. doi: 10.1038/onc.2014.458. Epub 2015 Jan 26. Oncogene. 2015. PMID: 25619832 Review. - Molecular Basis of Resveratrol-Induced Resensitization of Acquired Drug-Resistant Cancer Cells.
Choi CY, Lim SC, Lee TB, Han SI. Choi CY, et al. Nutrients. 2022 Feb 7;14(3):699. doi: 10.3390/nu14030699. Nutrients. 2022. PMID: 35277058 Free PMC article. Review. - Does Huntingtin play a role in selective macroautophagy?
Steffan JS. Steffan JS. Cell Cycle. 2010 Sep 1;9(17):3401-13. doi: 10.4161/cc.9.17.12718. Cell Cycle. 2010. PMID: 20703094 Free PMC article. - Macroautophagy regulates energy metabolism during effector T cell activation.
Hubbard VM, Valdor R, Patel B, Singh R, Cuervo AM, Macian F. Hubbard VM, et al. J Immunol. 2010 Dec 15;185(12):7349-57. doi: 10.4049/jimmunol.1000576. Epub 2010 Nov 8. J Immunol. 2010. PMID: 21059894 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous